Maze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal,...
MGI, a company committed to building core tools and technologies that drive innovation in life science, announced the collaboration with SeqOne, a leading provider...
